Treatment of CNS neoplasms in childhood by the Pediatric Oncology Group.
The incidence of brain tumors in children under 15 years of age in the United States is 2.4/100,000. Based upon a US population of approximately 60 million black and white children, there are only 1,200-1,500 newly diagnosed causes of CNS neoplasia diagnosed in children each year in the US. These relatively small numbers, the large geographic dispersion, and the multitude of histologic types, make it unlikely that all but a few medical centers can develop a large experience with this diverse group of tumors. The Brain Tumor Committee (BTC) of the Pediatric Oncology Group was formed, in part, to address this problem. Each of the four goals of the BTC will be addressed separately. A justification for the rationale for each goal is given, following which there is a discussion of how each goal is being met.
Cohen
M E
ME
Department of Neurology, State University of New York, School of Medicine and Biomedical Sciences, Buffalo.
Duffner
P K
PK
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D002648:Child; D004305:Dose-Response Relationship, Drug; D006801:Humans
D000970:Antineoplastic Agents